| Value | ₹633.0 Cr |
|---|
BSE filing, NSE: CSBBANK. Summary written from the filing by ALFA Finder's alert engine.
CSB Bank Ltd: key numbers
- Share price
- ₹307.50
- Market cap
- ₹5,335 Cr
- Revenue (annual)
- ₹4,505 Cr
- Net profit (annual)
- ₹633.2 Cr
- P/E (TTM)
- 7.8×Sector 19.7×
- Promoter holding
- 40.00%+0.00% QoQ
- FII holding
- 12.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CSB Bank Ltd
All →CSB Bank Results Update
CSB Bank reported Q2 FY27 PAT of ₹183 Crore, up 14% YoY. Deposits and advances grew 18% and 22% YoY respectively.
CSB Bank Investor Presentation: Key Takeaways
CSB Bank reported Q2 FY27 PAT of ₹183 Cr, up 14% YoY, driven by 20% growth in NII. Advances grew 22% YoY with gold loans comprising 53% of the mix.
CSB Bank Q2 FY27 Results: Net Profit ₹182.7 Cr, Up 14.0% YoY
CSB Bank Ltd reported revenue from operations of ₹1,339 Cr (+20.7% YoY) and net profit of ₹182.7 Cr (+14.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹182.7 Cr · +14.0% YoY
CSB Bank Price Movement Clarification
CSB Bank clarified it is not aware of any merger negotiations with IDBI Bank, responding to a BSE query regarding a recent media report.
CSB Bank Other Announcement
CSB Bank Ltd has filed its quarterly shareholding pattern disclosure as required under Regulation 31 of the SEBI Listing Regulations.
CSB Bank Board Meeting Date
CSB Bank has scheduled a board meeting on October 23, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Other results update announcements
All →Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.
Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Capital Small Finance Bank Results Update
Capital SFB's Q2 FY27 PAT rose 30.7% year-on-year to ₹45.61 crore, while advances grew 23.4%. Asset quality improved, with GNPA at 2.36% and NNPA at 1.12%.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.
Fiberweb (India) Results Update
Fiberweb India's Q2 FY27 press release shows total income of ₹30.99 crore, up 209.36% quarter-on-quarter. Net profit rose to ₹1.27 crore.